

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.99705317 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.06854727 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 5.04312347 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.78165557 |
| 5 | negative regulation of cell killing (GO:0031342) | 4.78165557 |
| 6 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.64703274 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.42933152 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 4.42933152 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.42933152 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.42933152 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.42933152 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 4.42933152 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.40602895 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.34401575 |
| 15 | cellular extravasation (GO:0045123) | 4.32290500 |
| 16 | response to peptidoglycan (GO:0032494) | 4.26865314 |
| 17 | regulation of gamma-delta T cell activation (GO:0046643) | 4.25657265 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 4.20039566 |
| 19 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.14291121 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 4.10576790 |
| 21 | negative regulation of interleukin-12 production (GO:0032695) | 4.10052133 |
| 22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.07047623 |
| 23 | positive regulation of B cell differentiation (GO:0045579) | 3.92319061 |
| 24 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.85618574 |
| 25 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.84248100 |
| 26 | detection of other organism (GO:0098543) | 3.82989954 |
| 27 | positive regulation of mast cell activation (GO:0033005) | 3.76242337 |
| 28 | detection of molecule of bacterial origin (GO:0032490) | 3.72813776 |
| 29 | detection of bacterium (GO:0016045) | 3.67670511 |
| 30 | neutrophil activation (GO:0042119) | 3.60774517 |
| 31 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.58824455 |
| 32 | granulocyte activation (GO:0036230) | 3.57085748 |
| 33 | detection of external biotic stimulus (GO:0098581) | 3.53632290 |
| 34 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.52282857 |
| 35 | regulation of mast cell degranulation (GO:0043304) | 3.51591015 |
| 36 | regulation of T cell tolerance induction (GO:0002664) | 3.44872219 |
| 37 | response to interleukin-15 (GO:0070672) | 3.44330146 |
| 38 | positive regulation of mast cell degranulation (GO:0043306) | 3.44140468 |
| 39 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.44140468 |
| 40 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.44101830 |
| 41 | myeloid cell activation involved in immune response (GO:0002275) | 3.38161952 |
| 42 | response to muramyl dipeptide (GO:0032495) | 3.34858732 |
| 43 | T cell migration (GO:0072678) | 3.31652697 |
| 44 | negative thymic T cell selection (GO:0045060) | 3.30859586 |
| 45 | regulation of B cell differentiation (GO:0045577) | 3.29991111 |
| 46 | B cell mediated immunity (GO:0019724) | 3.27788257 |
| 47 | B cell receptor signaling pathway (GO:0050853) | 3.24891422 |
| 48 | negative T cell selection (GO:0043383) | 3.23930012 |
| 49 | negative regulation of T cell mediated immunity (GO:0002710) | 3.23224827 |
| 50 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.21794785 |
| 51 | regulation of mast cell activation (GO:0033003) | 3.21048663 |
| 52 | dendritic cell chemotaxis (GO:0002407) | 3.20840732 |
| 53 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.19041638 |
| 54 | cellular response to interleukin-15 (GO:0071350) | 3.18361307 |
| 55 | regulation of tolerance induction (GO:0002643) | 3.16087992 |
| 56 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.15562445 |
| 57 | germinal center formation (GO:0002467) | 3.15015573 |
| 58 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.14037981 |
| 59 | cellular response to type I interferon (GO:0071357) | 3.13661952 |
| 60 | type I interferon signaling pathway (GO:0060337) | 3.13661952 |
| 61 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.12399863 |
| 62 | T-helper 1 type immune response (GO:0042088) | 3.10783673 |
| 63 | positive regulation of antigen processing and presentation (GO:0002579) | 3.10755362 |
| 64 | response to type I interferon (GO:0034340) | 3.10540730 |
| 65 | respiratory burst (GO:0045730) | 3.08555751 |
| 66 | regulation of hypersensitivity (GO:0002883) | 3.08209862 |
| 67 | myeloid dendritic cell differentiation (GO:0043011) | 3.07450222 |
| 68 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.06873228 |
| 69 | response to host immune response (GO:0052572) | 3.06310763 |
| 70 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.06310763 |
| 71 | detection of biotic stimulus (GO:0009595) | 3.05872477 |
| 72 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.04672961 |
| 73 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.04139952 |
| 74 | tolerance induction (GO:0002507) | 3.02924441 |
| 75 | positive thymic T cell selection (GO:0045059) | 3.01220645 |
| 76 | microglial cell activation (GO:0001774) | 3.00358010 |
| 77 | regulation of antigen processing and presentation (GO:0002577) | 3.00033299 |
| 78 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.99576194 |
| 79 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.97924699 |
| 80 | regulation of leukocyte degranulation (GO:0043300) | 2.97236682 |
| 81 | macrophage activation (GO:0042116) | 2.96950600 |
| 82 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.96064554 |
| 83 | myeloid dendritic cell activation (GO:0001773) | 2.94618563 |
| 84 | leukocyte aggregation (GO:0070486) | 2.93824185 |
| 85 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.92690870 |
| 86 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.92508551 |
| 87 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.90633972 |
| 88 | dendritic cell migration (GO:0036336) | 2.90592559 |
| 89 | defense response to protozoan (GO:0042832) | 2.88987483 |
| 90 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.85630272 |
| 91 | response to protozoan (GO:0001562) | 2.84802780 |
| 92 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.84563842 |
| 93 | leukocyte degranulation (GO:0043299) | 2.83212476 |
| 94 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.83126487 |
| 95 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.81948574 |
| 96 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.81382123 |
| 97 | cellular response to interferon-gamma (GO:0071346) | 2.81164079 |
| 98 | regulation of regulatory T cell differentiation (GO:0045589) | 2.77085814 |
| 99 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.75189685 |
| 100 | positive regulation of B cell mediated immunity (GO:0002714) | 2.74689473 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.00727135 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.90113518 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.30968161 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.91377833 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.53476311 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.35318158 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.33755585 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.29928349 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.11077238 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.00453902 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.87497452 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.82144010 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.76645106 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.68282102 |
| 15 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.63691522 |
| 16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.62894872 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.61552417 |
| 18 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.61408193 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.60429546 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.54371097 |
| 21 | * MYB_26560356_Chip-Seq_TH2_Human | 2.43740389 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 2.40787186 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.39537315 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.36201060 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 2.24138357 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.23055282 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.22890571 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.21094731 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.10121481 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.07808590 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 2.01352284 |
| 32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.00758189 |
| 33 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.00195885 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.99918121 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.97632101 |
| 36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.97440833 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.96864004 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85059603 |
| 39 | UTX_26944678_Chip-Seq_JUKART_Human | 1.79086183 |
| 40 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.73439881 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.72885660 |
| 42 | GATA1_19941826_ChIP-Seq_K562_Human | 1.71993598 |
| 43 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.66064219 |
| 44 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.62307086 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.61533117 |
| 46 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.61113193 |
| 47 | MAF_26560356_Chip-Seq_TH2_Human | 1.59564856 |
| 48 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.54158988 |
| 49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53205046 |
| 50 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49528991 |
| 51 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.45329086 |
| 52 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.43123898 |
| 53 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41247105 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.40743633 |
| 55 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40637026 |
| 56 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.39229585 |
| 57 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.38546578 |
| 58 | GATA3_26560356_Chip-Seq_TH2_Human | 1.37962392 |
| 59 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.37057136 |
| 60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.36911659 |
| 61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31598274 |
| 62 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30764913 |
| 63 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.29771357 |
| 64 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25449809 |
| 65 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25288818 |
| 66 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24452371 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23586347 |
| 68 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.22649839 |
| 69 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21403750 |
| 70 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20266821 |
| 71 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19167573 |
| 72 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.14533177 |
| 73 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14157115 |
| 74 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13961295 |
| 75 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13154991 |
| 76 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.11038545 |
| 77 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10837046 |
| 78 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10135069 |
| 79 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.07958614 |
| 80 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.05906822 |
| 81 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.05572585 |
| 82 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05368085 |
| 83 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04331776 |
| 84 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03735764 |
| 85 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00616379 |
| 86 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.99968500 |
| 87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97251929 |
| 88 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96426780 |
| 89 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.94239809 |
| 90 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89548062 |
| 91 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87841323 |
| 92 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.86465416 |
| 93 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86229280 |
| 94 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.86106983 |
| 95 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.84934081 |
| 96 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.83542826 |
| 97 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.81218735 |
| 98 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.80939297 |
| 99 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.80833426 |
| 100 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80517557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.04183781 |
| 2 | MP0003724_increased_susceptibility_to | 3.92028968 |
| 3 | MP0005671_abnormal_response_to | 3.81601067 |
| 4 | MP0003436_decreased_susceptibility_to | 3.75677288 |
| 5 | MP0003303_peritoneal_inflammation | 3.45776020 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.03163440 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.99487718 |
| 8 | MP0009785_altered_susceptibility_to | 2.97417916 |
| 9 | MP0002419_abnormal_innate_immunity | 2.95709799 |
| 10 | MP0001800_abnormal_humoral_immune | 2.91995763 |
| 11 | MP0001790_abnormal_immune_system | 2.87697005 |
| 12 | MP0005387_immune_system_phenotype | 2.87697005 |
| 13 | MP0005025_abnormal_response_to | 2.79477935 |
| 14 | MP0000685_abnormal_immune_system | 2.73425140 |
| 15 | MP0006082_CNS_inflammation | 2.68291937 |
| 16 | MP0002723_abnormal_immune_serum | 2.62253921 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.60858609 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.42249002 |
| 19 | MP0001819_abnormal_immune_cell | 2.40922918 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.35969172 |
| 21 | MP0003172_abnormal_lysosome_physiology | 2.14186909 |
| 22 | MP0005058_abnormal_lysosome_morphology | 2.10243996 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 2.05538367 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.02119337 |
| 25 | MP0010155_abnormal_intestine_physiology | 1.89065424 |
| 26 | MP0002405_respiratory_system_inflammati | 1.88408637 |
| 27 | MP0003763_abnormal_thymus_physiology | 1.88184909 |
| 28 | MP0001845_abnormal_inflammatory_respons | 1.87979350 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.87110011 |
| 30 | MP0004947_skin_inflammation | 1.84623009 |
| 31 | MP0002398_abnormal_bone_marrow | 1.83215575 |
| 32 | MP0000716_abnormal_immune_system | 1.81823542 |
| 33 | MP0005451_abnormal_body_composition | 1.73679538 |
| 34 | MP0009764_decreased_sensitivity_to | 1.67408021 |
| 35 | MP0000343_altered_response_to | 1.66066907 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.64283388 |
| 37 | MP0000604_amyloidosis | 1.54226413 |
| 38 | MP0003828_pulmonary_edema | 1.49491239 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.49475777 |
| 40 | MP0005310_abnormal_salivary_gland | 1.48562612 |
| 41 | MP0008260_abnormal_autophagy | 1.48199662 |
| 42 | MP0002429_abnormal_blood_cell | 1.47910066 |
| 43 | MP0008469_abnormal_protein_level | 1.47407930 |
| 44 | MP0002722_abnormal_immune_system | 1.43639846 |
| 45 | MP0003075_altered_response_to | 1.42399833 |
| 46 | MP0009840_abnormal_foam_cell | 1.41088909 |
| 47 | MP0003806_abnormal_nucleotide_metabolis | 1.40891815 |
| 48 | MP0009278_abnormal_bone_marrow | 1.40831275 |
| 49 | MP0003866_abnormal_defecation | 1.37202185 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.35590501 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.35590501 |
| 52 | MP0001853_heart_inflammation | 1.33264663 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.33164357 |
| 54 | MP0005167_abnormal_blood-brain_barrier | 1.29965461 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.28714639 |
| 56 | MP0002166_altered_tumor_susceptibility | 1.26846088 |
| 57 | MP0005166_decreased_susceptibility_to | 1.23532350 |
| 58 | MP0003690_abnormal_glial_cell | 1.22358372 |
| 59 | MP0000858_altered_metastatic_potential | 1.22292921 |
| 60 | MP0000703_abnormal_thymus_morphology | 1.14323446 |
| 61 | MP0001873_stomach_inflammation | 1.13828600 |
| 62 | MP0003448_altered_tumor_morphology | 1.04221406 |
| 63 | MP0004510_myositis | 1.02113605 |
| 64 | MP0002132_abnormal_respiratory_system | 1.01672056 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.00130273 |
| 66 | MP0009763_increased_sensitivity_to | 0.96959745 |
| 67 | MP0004883_abnormal_blood_vessel | 0.96648383 |
| 68 | MP0002139_abnormal_hepatobiliary_system | 0.88982279 |
| 69 | MP0000249_abnormal_blood_vessel | 0.87084853 |
| 70 | MP0002396_abnormal_hematopoietic_system | 0.86580936 |
| 71 | MP0001851_eye_inflammation | 0.86517386 |
| 72 | MP0005164_abnormal_response_to | 0.85974990 |
| 73 | MP0008004_abnormal_stomach_pH | 0.85427351 |
| 74 | MP0002138_abnormal_hepatobiliary_system | 0.84559774 |
| 75 | MP0002006_tumorigenesis | 0.84310107 |
| 76 | MP0002277_abnormal_respiratory_mucosa | 0.81006231 |
| 77 | MP0000015_abnormal_ear_pigmentation | 0.80780537 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 0.79400721 |
| 79 | MP0000920_abnormal_myelination | 0.78467395 |
| 80 | MP0004381_abnormal_hair_follicle | 0.77036133 |
| 81 | MP0003329_amyloid_beta_deposits | 0.71289636 |
| 82 | MP0001663_abnormal_digestive_system | 0.71143284 |
| 83 | MP0005390_skeleton_phenotype | 0.68957846 |
| 84 | MP0000371_diluted_coat_color | 0.68010745 |
| 85 | MP0002933_joint_inflammation | 0.66993234 |
| 86 | MP0004808_abnormal_hematopoietic_stem | 0.66082265 |
| 87 | MP0008874_decreased_physiological_sensi | 0.66035790 |
| 88 | MP0003183_abnormal_peptide_metabolism | 0.65208039 |
| 89 | MP0000609_abnormal_liver_physiology | 0.65199010 |
| 90 | MP0000569_abnormal_digit_pigmentation | 0.64216889 |
| 91 | MP0001727_abnormal_embryo_implantation | 0.63237302 |
| 92 | MP0003795_abnormal_bone_structure | 0.63140415 |
| 93 | MP0003045_fibrosis | 0.62293866 |
| 94 | MP0005075_abnormal_melanosome_morpholog | 0.58538549 |
| 95 | MP0005647_abnormal_sex_gland | 0.57426388 |
| 96 | MP0002332_abnormal_exercise_endurance | 0.54496737 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 0.54104695 |
| 98 | MP0005165_increased_susceptibility_to | 0.53502797 |
| 99 | MP0005535_abnormal_body_temperature | 0.53500189 |
| 100 | MP0009115_abnormal_fat_cell | 0.52413946 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 5.26599622 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.21648029 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.10214981 |
| 4 | Abnormality of macrophages (HP:0004311) | 5.02474248 |
| 5 | Myositis (HP:0100614) | 4.25081626 |
| 6 | Stomatitis (HP:0010280) | 4.17971775 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.07120965 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.07120965 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 4.07120965 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 4.00670112 |
| 11 | Obstructive lung disease (HP:0006536) | 4.00670112 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.93124778 |
| 13 | Orchitis (HP:0100796) | 3.89332847 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.83493603 |
| 15 | Optic neuritis (HP:0100653) | 3.82075356 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 3.82075356 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 3.76672437 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.61170208 |
| 19 | Recurrent skin infections (HP:0001581) | 3.59923158 |
| 20 | Meningitis (HP:0001287) | 3.55237772 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.53008335 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.53008335 |
| 23 | Systemic lupus erythematosus (HP:0002725) | 3.50682824 |
| 24 | Vacuolated lymphocytes (HP:0001922) | 3.49077370 |
| 25 | Spontaneous hematomas (HP:0007420) | 3.43603295 |
| 26 | Autoimmune thrombocytopenia (HP:0001973) | 3.41967246 |
| 27 | Increased cerebral lipofuscin (HP:0011813) | 3.38208019 |
| 28 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.36054671 |
| 29 | Vasculitis (HP:0002633) | 3.33433430 |
| 30 | Pulmonary infiltrates (HP:0002113) | 3.31765114 |
| 31 | T lymphocytopenia (HP:0005403) | 3.31345287 |
| 32 | Recurrent viral infections (HP:0004429) | 3.30264452 |
| 33 | Abnormality of T cell number (HP:0011839) | 3.26149566 |
| 34 | Gastrointestinal infarctions (HP:0005244) | 3.23124177 |
| 35 | Hemoptysis (HP:0002105) | 3.02849614 |
| 36 | Increased IgM level (HP:0003496) | 2.96967930 |
| 37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.94381601 |
| 38 | Gingivitis (HP:0000230) | 2.92954102 |
| 39 | Encephalitis (HP:0002383) | 2.91924179 |
| 40 | Abnormality of T cells (HP:0002843) | 2.90908724 |
| 41 | Pustule (HP:0200039) | 2.85002295 |
| 42 | Keratoconjunctivitis sicca (HP:0001097) | 2.84816715 |
| 43 | Urticaria (HP:0001025) | 2.82626006 |
| 44 | Autoimmune hemolytic anemia (HP:0001890) | 2.81020792 |
| 45 | Loss of speech (HP:0002371) | 2.68398379 |
| 46 | Hypertensive crisis (HP:0100735) | 2.68141507 |
| 47 | Colitis (HP:0002583) | 2.63868957 |
| 48 | Keratoconjunctivitis (HP:0001096) | 2.62856139 |
| 49 | Chest pain (HP:0100749) | 2.59168682 |
| 50 | Increased IgE level (HP:0003212) | 2.59068045 |
| 51 | Abnormality of T cell physiology (HP:0011840) | 2.59042539 |
| 52 | Dysostosis multiplex (HP:0000943) | 2.57906620 |
| 53 | Leukocytosis (HP:0001974) | 2.55954942 |
| 54 | Granulocytopenia (HP:0001913) | 2.54630529 |
| 55 | Cellulitis (HP:0100658) | 2.54268073 |
| 56 | Osteomyelitis (HP:0002754) | 2.47863729 |
| 57 | Agammaglobulinemia (HP:0004432) | 2.45354293 |
| 58 | Chronic diarrhea (HP:0002028) | 2.44518583 |
| 59 | Arterial thrombosis (HP:0004420) | 2.42419133 |
| 60 | Inflammation of the large intestine (HP:0002037) | 2.42061395 |
| 61 | Epistaxis (HP:0000421) | 2.41271648 |
| 62 | Abnormality of the prostate (HP:0008775) | 2.38193165 |
| 63 | Polycythemia (HP:0001901) | 2.36951055 |
| 64 | Hepatosplenomegaly (HP:0001433) | 2.36282236 |
| 65 | IgG deficiency (HP:0004315) | 2.35561483 |
| 66 | Pulmonary embolism (HP:0002204) | 2.35248546 |
| 67 | IgM deficiency (HP:0002850) | 2.34421337 |
| 68 | Prolonged bleeding time (HP:0003010) | 2.32355707 |
| 69 | Gastrointestinal stroma tumor (HP:0100723) | 2.30073473 |
| 70 | Panhypogammaglobulinemia (HP:0003139) | 2.28645812 |
| 71 | Gastrointestinal inflammation (HP:0004386) | 2.28533735 |
| 72 | Disinhibition (HP:0000734) | 2.27714486 |
| 73 | Petechiae (HP:0000967) | 2.26250105 |
| 74 | Lymphopenia (HP:0001888) | 2.25014412 |
| 75 | Gangrene (HP:0100758) | 2.19107716 |
| 76 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.16545041 |
| 77 | Hypergammaglobulinemia (HP:0010702) | 2.13971373 |
| 78 | Anorexia (HP:0002039) | 2.12621635 |
| 79 | Myocardial infarction (HP:0001658) | 2.12051301 |
| 80 | Eosinophilia (HP:0001880) | 2.11517489 |
| 81 | Purpura (HP:0000979) | 2.09914615 |
| 82 | Increased serum ferritin (HP:0003281) | 2.08324430 |
| 83 | Abnormality of the pleura (HP:0002103) | 2.06729531 |
| 84 | Polyneuropathy (HP:0001271) | 2.05854127 |
| 85 | Recurrent bronchitis (HP:0002837) | 2.03855861 |
| 86 | Skin rash (HP:0000988) | 2.02863677 |
| 87 | Vertigo (HP:0002321) | 2.01611438 |
| 88 | Glomerulonephritis (HP:0000099) | 2.01162774 |
| 89 | Premature loss of primary teeth (HP:0006323) | 2.00723664 |
| 90 | Amyloidosis (HP:0011034) | 1.99749681 |
| 91 | Gingival bleeding (HP:0000225) | 1.98658770 |
| 92 | Pulmonary fibrosis (HP:0002206) | 1.98590616 |
| 93 | Recurrent sinusitis (HP:0011108) | 1.97290106 |
| 94 | Restrictive lung disease (HP:0002091) | 1.97272433 |
| 95 | Glomerulopathy (HP:0100820) | 1.97075858 |
| 96 | Joint swelling (HP:0001386) | 1.95540759 |
| 97 | IgA deficiency (HP:0002720) | 1.94173715 |
| 98 | Hematochezia (HP:0002573) | 1.93848226 |
| 99 | Abnormality of the peritoneum (HP:0002585) | 1.93497982 |
| 100 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.92877994 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.91312570 |
| 2 | BLK | 3.84270237 |
| 3 | TAOK3 | 3.83367835 |
| 4 | MAP4K1 | 3.50389829 |
| 5 | TYK2 | 2.70685599 |
| 6 | MAP3K14 | 2.64340517 |
| 7 | TXK | 2.40865506 |
| 8 | CSK | 2.35396074 |
| 9 | BMPR2 | 2.35148039 |
| 10 | IRAK4 | 2.29485961 |
| 11 | FES | 2.23472228 |
| 12 | JAK3 | 2.01567849 |
| 13 | SYK | 2.00718511 |
| 14 | PRPF4B | 1.96878390 |
| 15 | ERN1 | 1.93762441 |
| 16 | MAP3K13 | 1.89469081 |
| 17 | MAP2K3 | 1.85449935 |
| 18 | BTK | 1.84580457 |
| 19 | TBK1 | 1.84180333 |
| 20 | ZAP70 | 1.83720665 |
| 21 | MATK | 1.78547545 |
| 22 | IRAK3 | 1.78229370 |
| 23 | JAK1 | 1.62259874 |
| 24 | IKBKE | 1.58149567 |
| 25 | GRK6 | 1.55487525 |
| 26 | HCK | 1.52206406 |
| 27 | JAK2 | 1.51641982 |
| 28 | LYN | 1.48810544 |
| 29 | TEC | 1.47000020 |
| 30 | IKBKB | 1.45381793 |
| 31 | ITK | 1.39150606 |
| 32 | KSR2 | 1.32689908 |
| 33 | FGR | 1.27899934 |
| 34 | CSF1R | 1.25368433 |
| 35 | TNK2 | 1.23379423 |
| 36 | LCK | 1.23359450 |
| 37 | MAP3K1 | 1.22745652 |
| 38 | PDK2 | 1.21374650 |
| 39 | TGFBR2 | 1.15457837 |
| 40 | GRK7 | 1.15054288 |
| 41 | KIT | 1.11696336 |
| 42 | MAP3K11 | 1.07522588 |
| 43 | MAP3K3 | 1.04609994 |
| 44 | TAOK2 | 1.01092730 |
| 45 | MAPK12 | 0.93272546 |
| 46 | PIK3CG | 0.93018231 |
| 47 | MARK3 | 0.91370616 |
| 48 | EPHB1 | 0.87346469 |
| 49 | PDK1 | 0.86136593 |
| 50 | TRPM7 | 0.85538770 |
| 51 | MAP3K2 | 0.82373320 |
| 52 | PDPK1 | 0.80254540 |
| 53 | STK10 | 0.76515396 |
| 54 | PIM1 | 0.76327274 |
| 55 | CDC42BPA | 0.76147747 |
| 56 | IRAK2 | 0.70940778 |
| 57 | MAPK7 | 0.70609102 |
| 58 | IRAK1 | 0.70440273 |
| 59 | MAP2K2 | 0.70182282 |
| 60 | CLK1 | 0.64677631 |
| 61 | TAOK1 | 0.64042120 |
| 62 | YES1 | 0.60671644 |
| 63 | TIE1 | 0.57801365 |
| 64 | PRKCQ | 0.55560018 |
| 65 | MOS | 0.53582341 |
| 66 | MAP2K6 | 0.52239313 |
| 67 | NME2 | 0.50280566 |
| 68 | FYN | 0.49632753 |
| 69 | MAPKAPK3 | 0.46880736 |
| 70 | SIK3 | 0.46743032 |
| 71 | FGFR3 | 0.45072687 |
| 72 | RAF1 | 0.44699440 |
| 73 | EPHA3 | 0.43824602 |
| 74 | CAMKK2 | 0.42927455 |
| 75 | FGFR4 | 0.41886124 |
| 76 | LRRK2 | 0.41535000 |
| 77 | MAP3K7 | 0.40952085 |
| 78 | MAP3K6 | 0.40724513 |
| 79 | TESK2 | 0.40351588 |
| 80 | MAPKAPK2 | 0.40303514 |
| 81 | RPS6KC1 | 0.39605290 |
| 82 | RPS6KL1 | 0.39605290 |
| 83 | MAP3K8 | 0.39526324 |
| 84 | MAPK11 | 0.38386027 |
| 85 | NEK9 | 0.37270033 |
| 86 | MAP3K5 | 0.37169129 |
| 87 | KDR | 0.36705044 |
| 88 | TRIB3 | 0.36507907 |
| 89 | CDK6 | 0.36500804 |
| 90 | ABL1 | 0.35648504 |
| 91 | DAPK2 | 0.34925647 |
| 92 | BMX | 0.34684588 |
| 93 | CHUK | 0.33346929 |
| 94 | ACVR1B | 0.33148274 |
| 95 | MAPK4 | 0.33123187 |
| 96 | PRKG2 | 0.33035254 |
| 97 | PTK6 | 0.31550058 |
| 98 | HIPK2 | 0.31448360 |
| 99 | RPS6KA6 | 0.31180819 |
| 100 | MARK2 | 0.31069457 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.52195755 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.30668130 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.28264309 |
| 4 | Asthma_Homo sapiens_hsa05310 | 3.20930613 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.20304652 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 3.16181504 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.72094321 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.59552189 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.57828298 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.52626364 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 2.21419098 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.15859708 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.12836315 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.10473031 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.09161492 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.07817747 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.07458631 |
| 18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.97696877 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.95432057 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.87188295 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.85821280 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.72782726 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.68931812 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.61887443 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.60010639 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.58743867 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.56458348 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.49619334 |
| 29 | Lysosome_Homo sapiens_hsa04142 | 1.49220224 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.49089881 |
| 31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.47916100 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.47402022 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.39775168 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.39519236 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.39394562 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.36094509 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34695032 |
| 38 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.29054948 |
| 39 | Pertussis_Homo sapiens_hsa05133 | 1.23554988 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21105845 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.20484201 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.20216278 |
| 43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.06020298 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 0.96497258 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.95875241 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.95460179 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 0.92370264 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 0.90784328 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 0.87369896 |
| 50 | Platelet activation_Homo sapiens_hsa04611 | 0.79571453 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 0.78307542 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76447786 |
| 53 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.74538695 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73905133 |
| 55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71552840 |
| 56 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.70110185 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68278539 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64035022 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63625004 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62237899 |
| 61 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60056120 |
| 62 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59797268 |
| 63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.57959162 |
| 64 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57751958 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56693032 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52349905 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51899518 |
| 68 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48674032 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48560707 |
| 70 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48194243 |
| 71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48140311 |
| 72 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.47368346 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45452281 |
| 74 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.44549750 |
| 75 | Endocytosis_Homo sapiens_hsa04144 | 0.42119597 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.41358648 |
| 77 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38776407 |
| 78 | Amoebiasis_Homo sapiens_hsa05146 | 0.38006577 |
| 79 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36206266 |
| 80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35977697 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32740200 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31102682 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.30851400 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30034294 |
| 85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28111395 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.27885916 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.24561735 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23552364 |
| 89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.20138843 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20083619 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.18942900 |
| 92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.18381249 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.17966332 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.15750988 |
| 95 | Bladder cancer_Homo sapiens_hsa05219 | 0.14235618 |
| 96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.14187605 |
| 97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.13494017 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12805259 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.10973341 |
| 100 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.07329825 |

